Pharmac considers funding at-home urine tests for medical abortion follow-up, potentially replacing blood tests.

Pharmac, New Zealand's pharmaceutical funding agency, is considering funding at-home low sensitivity urine tests to confirm the completion of medical abortions, potentially replacing blood tests. This change aims to improve accessibility, as many individuals currently do not complete follow-up tests. If approved, about 9,300 people could use the tests in the first year. Public consultation runs until October 30, with a possible rollout on December 1, 2024.

October 14, 2024
3 Articles